Evaluation of Bone Mineral Metabolism After Liver Transplantation by Bone Mineral Densitometry and Biochemical Markers.
暂无分享,去创建一个
Y. Turkoz | S. Akbulut | S. Yılmaz | A. Baskiran | M. Uremis | C. Koc | S. Usta | I. Garzali | Ali Aloun | Z. Kucukakcali | K. Sarici
[1] M. García-Alanís,et al. Bone Disease and Liver Transplantation: A Review. , 2021, Transplantation proceedings.
[2] K. L. Wong,et al. Bisphosphonate therapy after liver transplant improves bone mineral density and reduces fracture rates: an updated systematic review and meta‐analysis , 2021, Transplant international : official journal of the European Society for Organ Transplantation.
[3] C. Rajapakse,et al. The Effect of Inflammation on Bone , 2021, Frontiers in Physiology.
[4] A. Rivas,et al. Evaluation of Factors Associated With Fracture and Loss of Bone Mineral Density Within 1 Year After Liver Transplantation. , 2020, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[5] M. Greenblatt,et al. Osteoblast-Osteoclast Communication and Bone Homeostasis , 2020, Cells.
[6] K. Kovvuru,et al. Risk Factors and Management of Osteoporosis Post-Transplant , 2020, Medicina.
[7] D. J. Kim,et al. Bone Diseases in Patients with Chronic Liver Disease , 2019, International journal of molecular sciences.
[8] I. Akkawi,et al. Osteoporosis: Current Concepts , 2018, Joints.
[9] Feihu Chen,et al. Osteoclast-Derived Extracellular Vesicles: Novel Regulators of Osteoclastogenesis and Osteoclast–Osteoblasts Communication in Bone Remodeling , 2018, Front. Physiol..
[10] E. Schwarz,et al. Osteoblast–osteoclast interactions , 2018, Connective tissue research.
[11] Chih-Hwa Chen,et al. Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives , 2017, Biomarker Research.
[12] M. Greenblatt,et al. Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease. , 2017, Clinical chemistry.
[13] L. A. A. Santos,et al. Diagnosis and Management of Cirrhosis-Related Osteoporosis , 2016, BioMed research international.
[14] J. Siddiqui,et al. Physiological Bone Remodeling: Systemic Regulation and Growth Factor Involvement. , 2016, Physiology.
[15] K. Wilczyński,et al. Osteoporosis in liver disease: pathogenesis and management , 2016, Therapeutic advances in endocrinology and metabolism.
[16] R. Chapurlat,et al. Novel biological markers of bone: from bone metabolism to bone physiology. , 2016, Rheumatology.
[17] J. Compston,et al. Biochemical markers of bone turnover – uses and limitations , 2014, Annals of clinical biochemistry.
[18] H. Datta,et al. The clinical utility of bone marker measurements in osteoporosis , 2013, Journal of Translational Medicine.
[19] J. Compston,et al. Fracture incidence after liver transplantation: results of a 10 year audit , 2011, Gut.
[20] A. Cheung. Post-liver transplantation osteoporosis. , 2001, Journal of hepatology.
[21] A. Mohamed. An overview of bone cells and their regulating factors of differentiation. , 2008, The Malaysian journal of medical sciences : MJMS.
[22] T. Starzl,et al. The quality of life after liver transplantation. , 1979, Transplantation proceedings.